Target intelligence / Profile preview

Novel transcript, sense intronic to RASL10A (ENSG00000273216)

Target
ENSG00000273216
Molecular classification
Other (noncoding RNA, possibly long noncoding RNA/lncRNA)
01

Overview

ENSG00000273216 is a novel, uncharacterized sense noncoding RNA transcript located in the intronic region of the *RAS Like Family 10 Member A* (RASL10A) gene[1][5][9]. There is no evidence to suggest it encodes a protein or that it functions as a therapeutic target. The molecular classification would likely be designated as "long noncoding RNA" (lncRNA) or generic "noncoding RNA," pending further characterization, although neither its biological functions nor its potential involvement in disease have been annotated. The gene's description is primarily based on its genomic location and lack of protein-coding capability; it is distinct from RASL10A itself, which is a small GTPase with known roles in cell signaling and disease[3][7][9].

Other names
Novel transcript, sense intronic to RASL10AENSG00000273216lnc-RASL10A-1:2
02

Mechanism of action

None (no mechanisms of action as a therapeutic target, since no drugs interact with it)

03

Biological functions

Other (no described biological function; not characterized in the literature or databases as having a specific role)
04

Disease associations

Other (no direct association with disease roles; the parent gene RASL10A is implicated in cancer and other conditions, but ENSG00000273216 itself has no disease annotation)
05

Safety considerations

None (not a therapeutic target; no safety or therapeutic challenges reported)
06

Interacting drugs

None (no drugs known to interact with this uncharacterized noncoding RNA transcript)
07

Biomarkers

None (not used as a biomarker for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on Novel transcript, sense intronic to RASL10A (ENSG00000273216).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to RASL10A (ENSG00000273216).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call